{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:00:40Z","timestamp":1790438440220,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008914","name":"Ontario Brain Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jpsychires.2018.12.007","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T23:32:50Z","timestamp":1544225570000},"page":"38-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Plasma microRNA expression levels and their targeted pathways in patients with major depressive disorder who are responsive to duloxetine treatment"],"prefix":"10.1016","volume":"110","author":[{"given":"Helena Kyunghee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Tyryshkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nika","family":"Elmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4175-0719","authenticated-orcid":false,"given":"Moyez","family":"Dharsee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojib","family":"Javadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony L.","family":"Vaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Andreazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Feilotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpsychires.2018.12.007_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4331\/wjbc.v5.i4.409","article-title":"New insight in expression, transport, and secretion of brain-derived neurotrophic factor: implications in brain-related diseases","volume":"5","author":"Adachi","year":"2014","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.jpsychires.2018.12.007_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbi.2013.10.017","article-title":"NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder","volume":"36","author":"Alcocer-G\u00f3mez","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.12.007_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.jpsychires.2018.12.007_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/archpsyc.1989.01810030049007","article-title":"Reduction of prefrontal cortex glucose metabolism common to three types of depression","volume":"46","author":"Baxter","year":"1989","journal-title":"Arch. Gen. Psychiatr."},{"issue":"7","key":"10.1016\/j.jpsychires.2018.12.007_bib5","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.euroneuro.2012.06.013","article-title":"Blood microRNA changes in depressed patients during antidepressant treatment","volume":"23","author":"Bocchio-Chiavetto","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.12.007_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0165-0327(86)90036-4","article-title":"Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness","volume":"10","author":"Buchsbaum","year":"1986","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2018.12.007_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpsychires.2015.07.023","article-title":"Comparison of plasma MicroRNA levels in drug naive, first episode depressed patients and healthy controls","volume":"69","author":"Camkurt","year":"2015","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.12.007_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/092986711794088353","article-title":"Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?","volume":"18","author":"Catena-Dell'Osso","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.jpsychires.2018.12.007_bib9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00406-007-0728-0","article-title":"What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated?","volume":"257","author":"Cz\u00e9h","year":"2007","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.12.007_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/mp.2016.73","article-title":"Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorder","volume":"22","author":"Ernst","year":"2017","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.12.007_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/nar\/gkr688","article-title":"miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades","volume":"40","author":"Friedlander","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpsychires.2018.12.007_bib12","series-title":"Dose-finding Study with Lu AA24530 in Major Depressive Disorder","author":"Lundbeck","year":"2008"},{"key":"10.1016\/j.jpsychires.2018.12.007_bib13","series-title":"Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 Mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder","author":"Lundbeck","year":"2008"},{"key":"10.1016\/j.jpsychires.2018.12.007_bib14","series-title":"Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 Mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder","author":"Lundbeck","year":"2008"},{"issue":"400","key":"10.1016\/j.jpsychires.2018.12.007_bib15","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/01621459.1987.10478551","article-title":"Fine-tuning some resistant rules for outlier labeling","volume":"82","author":"Hoaglin","year":"1987","journal-title":"J. Am. Stat. Assoc."},{"issue":"9","key":"10.1016\/j.jpsychires.2018.12.007_bib16","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jpsychires.2013.05.002","article-title":"A genome-wide association study of a sustained pattern of antidepressant response","volume":"47","author":"Hunter","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2018.12.007_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbi.2012.12.008","article-title":"The inflammasome: pathways linking psychological stress, depression, and systemic illnesses","volume":"31","author":"Iwata","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpsychires.2018.12.007_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pnpbp.2016.01.008","article-title":"Neuropathological relationship between major depression and dementia: a hypothetical model and review","volume":"67","author":"Kim","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.jpsychires.2018.12.007_bib19","doi-asserted-by":"crossref","first-page":"e75184","DOI":"10.1371\/journal.pone.0075184","article-title":"Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers","volume":"8","author":"Koberle","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2018.12.007_bib20","doi-asserted-by":"crossref","first-page":"15497","DOI":"10.1038\/ncomms15497","article-title":"MicroRNAs 146a\/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK\/Wnt-system genes","volume":"8","author":"Lopez","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpsychires.2018.12.007_bib21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jad.2016.04.021","article-title":"Peripheral whole blood microRNA alterations in major depression and bipolar disorder","volume":"200","author":"Maffioletti","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2018.12.007_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jad.2014.02.010","article-title":"Apoptosis-related proteins and proliferation markers in the orbitofrontal cortex in major depressive disorder","volume":"158","author":"Miguel-Hidalgo","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2018.12.007_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpsychires.2014.04.007","article-title":"Reduced connexin 43 immunolabeling in the orbitofrontal cortex in alcohol dependence and depression","volume":"55","author":"Miguel-Hidalgo","year":"2014","journal-title":"J. Psychiatr. Res."},{"issue":"11","key":"10.1016\/j.jpsychires.2018.12.007_bib24","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1176\/appi.ajp.161.11.2081","article-title":"A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects","volume":"161","author":"O'Brien","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.jpsychires.2018.12.007_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jad.2005.11.015","article-title":"Cytokine profiles in bipolar affective disorder: focus on acutely ill patients","volume":"90","author":"O'Brien","year":"2006","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.12.007_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1590\/S0100-879X2008000400012","article-title":"Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders","volume":"41","author":"Oliveira","year":"2008","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"8","key":"10.1016\/j.jpsychires.2018.12.007_bib27","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0006-3223(00)00950-1","article-title":"Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells","volume":"48","author":"Rajkowska","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2018.12.007_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pnpbp.2015.06.001","article-title":"Antidepressant drug action--From rapid changes on network function to network rewiring","volume":"64","author":"Rantamaki","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2018.12.007_bib29","doi-asserted-by":"crossref","first-page":"70982","DOI":"10.18632\/oncotarget.20237","article-title":"Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance","volume":"8","author":"Ren","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.jpsychires.2018.12.007_bib30","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1073\/pnas.93.9.3908","article-title":"Hippocampal atrophy in recurrent major depression","volume":"93","author":"Sheline","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.jpsychires.2018.12.007_bib31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/mp.2010.52","article-title":"Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression","volume":"16","author":"Shelton","year":"2011","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.12.007_bib32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-3223(03)00181-1","article-title":"Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants","volume":"54","author":"Shimizu","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.jpsychires.2018.12.007_bib33","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1017\/S1461145713000436","article-title":"Biological substrates underpinning diagnosis of major depression","volume":"16","author":"Sibille","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.12.007_bib34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12888-014-0321-9","article-title":"Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies","volume":"14","author":"Su","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"D1","key":"10.1016\/j.jpsychires.2018.12.007_bib35","doi-asserted-by":"crossref","first-page":"D331","DOI":"10.1093\/nar\/gkw1108","article-title":"Expansion of the gene ontology knowledgebase and resources","volume":"45","author":"The Gene Ontology","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"2\u20133","key":"10.1016\/j.jpsychires.2018.12.007_bib36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0920-9964(03)00181-6","article-title":"Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium","volume":"67","author":"Uranova","year":"2004","journal-title":"Schizophr. Res."},{"issue":"W1","key":"10.1016\/j.jpsychires.2018.12.007_bib37","doi-asserted-by":"crossref","first-page":"W460","DOI":"10.1093\/nar\/gkv403","article-title":"DIANA-miRPath v3.0: deciphering microRNA function with experimental support","volume":"43","author":"Vlachos","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.jpsychires.2018.12.007_bib38","doi-asserted-by":"crossref","first-page":"e0121975","DOI":"10.1371\/journal.pone.0121975","article-title":"Identification of differential microRNAs in cerebrospinal fluid and serum of patients with major depressive disorder","volume":"10","author":"Wan","year":"2015","journal-title":"PLoS One"},{"issue":"Pt C","key":"10.1016\/j.jpsychires.2018.12.007_bib39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pnpbp.2017.04.026","article-title":"Effect of antidepressant treatment on peripheral inflammation markers - a meta-analysis","volume":"80","author":"Wiedlocha","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395618309646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395618309646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:11:45Z","timestamp":1758366705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395618309646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":39,"alternative-id":["S0022395618309646"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.12.007","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma microRNA expression levels and their targeted pathways in patients with major depressive disorder who are responsive to duloxetine treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}